Agenda
Below you find the agenda. All the presentations will be sent live on the conference days. You can already add presentations to your calendar, you will then receive a reminder by email 15 minutes before the presentation start - click on the presentation and press "Add".
To join a presentation on the conference day, please click on the slot and press “Check in”.
Introduction by Pareto Securities
Pareto Securities, Ingeborg Magnusson, Matilda Karlsson, Dan Akschuti (Equity Research)
Wednesday September 2, 2020 08:00 - 08:30 CEST Room 1
Vitrolife
Vitrolife, Thomas Axelsson (CEO)
Wednesday September 2, 2020 08:30 - 09:00 CEST Room 1
Calliditas Therapeutics
Calliditas Therapeutics, Renee Aguiar-Lucander (CEO)
Wednesday September 2, 2020 08:30 - 09:00 CEST Room 2
Q-Linea
Q-Linea, Jonas Jarvius (CEO)
Wednesday September 2, 2020 09:00 - 09:30 CEST Room 1
Alligator Bioscience
Alligator Bioscience, Per Norlén (CEO)
Wednesday September 2, 2020 09:00 - 09:30 CEST Room 2
SyntheticMR
SyntheticMR, Ulrik Harrysson (CEO)
Wednesday September 2, 2020 09:30 - 10:00 CEST Room 1
Ascelia Pharma
Ascelia Pharma, Magnus Corfitzen (CEO)
Wednesday September 2, 2020 09:30 - 10:00 CEST Room 2
Bonesupport
Bonesupport, Emil Billbäck (CEO)
Wednesday September 2, 2020 10:00 - 10:30 CEST Room 1
PledPharma
PledPharma, Mervin Nicklas Westerholm (CEO & President)
Wednesday September 2, 2020 10:00 - 10:30 CEST Room 2
Bioinvent
Bioinvent, Martin Welschof (CEO)
Wednesday September 2, 2020 10:30 - 11:00 CEST Room 2
Swedencare
Swedencare, Håkan Lagerberg (CEO)
Wednesday September 2, 2020 11:00 - 11:30 CEST Room 1
Corline Biomedical
Corline Biomedical, Henrik Nittmar (CEO)
Wednesday September 2, 2020 11:00 - 11:30 CEST Room 2
Implantica
Implantica, Peter Forsell (CEO & Founder)
Wednesday September 2, 2020 11:30 - 12:00 CEST Room 1
Targovax
Targovax, Torbjørn Furuseth (CFO )
Wednesday September 2, 2020 11:30 - 12:00 CEST Room 2
Carasent
Carasent, Niclas Hugosson (Business Development), Johan Lindqvist (COB Carasent ASA), Dennis Höjer (MD Evimeria EMR AB)
Wednesday September 2, 2020 12:30 - 13:00 CEST Room 1
Vicore Pharma
Vicore Pharma, Carl-Johan Dalsgaard (CEO)
Wednesday September 2, 2020 12:30 - 13:00 CEST Room 2
Iconovo
Iconovo, Johan Wäborg (CEO)
Wednesday September 2, 2020 13:00 - 13:30 CEST Room 1
Gentian Diagnostics
Gentian Diagnostics, Hilja Ibert (CEO)
Wednesday September 2, 2020 13:00 - 13:30 CEST Room 2
Genovis
Genovis, Fredrik Olsson (CEO)
Wednesday September 2, 2020 13:30 - 14:00 CEST Room 1
InDex Pharmaceuticals
Index Pharmaceuticals, Peter Zerhouni (CEO)
Wednesday September 2, 2020 13:30 - 14:00 CEST Room 2
Arctic Zymes
ArcticZymes Technologies, Jethro Holter (CEO)
Wednesday September 2, 2020 14:00 - 14:30 CEST Room 1
Oncopeptides
Oncopeptides, Marty Duvall (CEO), Jacob Lindberg (CSO)
Wednesday September 2, 2020 14:00 - 14:30 CEST Room 2
Medistim
Medistim, Thomas Jakobsen (CFO ), Kari Krogstad (President and CEO )
Wednesday September 2, 2020 14:30 - 15:00 CEST Room 1
Camurus
Camurus, Fredrik Tiberg (President & CEO)
Wednesday September 2, 2020 14:30 - 15:00 CEST Room 2
IRRAS
IRRAS, Will Martin (President & CCO)
Wednesday September 2, 2020 15:00 - 15:30 CEST Room 1
Asarina Pharma
Asarina Pharma, Peter Nordkild (CEO)
Wednesday September 2, 2020 15:00 - 15:30 CEST Room 2
Xvivo Perfusion
Xvivo Perfusion, Dag Andersson (CEO)
Wednesday September 2, 2020 15:30 - 16:00 CEST Room 1
Bio-Works
Bio-Works, Jonathan Royce (CEO)
Wednesday September 2, 2020 15:30 - 16:00 CEST Room 2
CellaVision
CellaVision, Maria Morin (VP HR & Corporate Communications)
Wednesday September 2, 2020 16:00 - 16:30 CEST Room 1
Immunovia
Immunovia, Mats Grahn (CEO)
Wednesday September 2, 2020 16:00 - 16:30 CEST Room 2
Biogaia
BioGaia, Isabelle Ducellier (CEO)
Thursday September 3, 2020 08:30 - 09:00 CEST Room 1
Sobi
Sobi, Henrik Stenqvist (CFO )
Thursday September 3, 2020 08:30 - 09:00 CEST Room 2
Cellink
Cellink, Erik Gatenholm (CEO & Co-Founder)
Thursday September 3, 2020 09:00 - 09:30 CEST Room 1
X-Spray Pharma
X-Spray Pharma, Per Andersson (CEO)
Thursday September 3, 2020 09:00 - 09:30 CEST Room 2
Getinge
Getinge, Lars Mattsson (Head of IR), Mattias Perjos (President & CEO)
Thursday September 3, 2020 09:30 - 10:00 CEST Room 1
Intervacc
Intervacc, Andreas Andersson (CEO)
Thursday September 3, 2020 09:30 - 10:00 CEST Room 2
Mentice
Mentice, Henrik Storm, Göran Malmberg (CEO)
Thursday September 3, 2020 10:00 - 10:30 CEST Room 1
Isofol
Isofol Medical, Jarl Ulf Jungnelius (CEO)
Thursday September 3, 2020 10:00 - 10:30 CEST Room 2
Raysearch
Raysearch Laboratories, Johan Löf (CEO)
Thursday September 3, 2020 10:30 - 11:00 CEST Room 1
Xbrane Biopharma
Xbrane Biopharma, Martin Åmark (CEO & Head of IR)
Thursday September 3, 2020 10:30 - 11:00 CEST Room 2
Boule Diagnostics
Boule Diagnostics, Jesper Söderqvist (CEO)
Thursday September 3, 2020 11:00 - 11:30 CEST Room 1
PCI Biotech
PCI Biotech, Per Walday (Chief Executive Officer)
Thursday September 3, 2020 11:00 - 11:30 CEST Room 2
Midsona
Midsona, Peter Åsberg (CEO)
Thursday September 3, 2020 11:30 - 12:00 CEST Room 1
BerGenBio
BergenBio, Richard Godfrey
Thursday September 3, 2020 11:30 - 12:00 CEST Room 2
Elekta
Elekta, Cecilia Ketels (Head of Investor Relations)
Thursday September 3, 2020 12:30 - 13:00 CEST Room 1
Cantargia
Cantargia, Göran Forsberg (CEO)
Thursday September 3, 2020 12:30 - 13:00 CEST Room 2
Arjo
Arjo, Daniel Fäldt (CFO)
Thursday September 3, 2020 13:00 - 13:30 CEST Room 1
Orexo
Orexo, Nikolaj Sörensen
Thursday September 3, 2020 13:00 - 13:30 CEST Room 2
Surgical Science
Surgical Science, Gisli Hennermark (CEO)
Thursday September 3, 2020 13:30 - 14:00 CEST Room 1
Infant Bacterial Therapeutics
Infant Bacterial Therapeutics, Staffan Strömberg (CEO)
Thursday September 3, 2020 13:30 - 14:00 CEST Room 2
Probi
Probi, Henrik Lundkvist (CFO), Tom Rönnlund (CEO)
Thursday September 3, 2020 14:00 - 14:30 CEST Room 1
BioArctic
BioArctic, Gunilla Osswald (CEO)
Thursday September 3, 2020 14:00 - 14:30 CEST Room 2
Oxthera
Oxthera, Matthew Gantz (CEO)
Thursday September 3, 2020 14:30 - 15:00 CEST Room 1
Biovica
Biovica, Anders Rylander (CEO)
Thursday September 3, 2020 14:30 - 15:00 CEST Room 2
Sedana Medical
Sedana Medical, Christer Ahlberg (CEO)
Thursday September 3, 2020 15:00 - 15:30 CEST Room 1
Nordic Nanovector
Nordic Nanovector, Lars Nieba (Interim CEO)
Thursday September 3, 2020 15:00 - 15:30 CEST Room 2
IRLAB Therapeutics
IRLAB Therapeutics, Nicholas Waters (CEO)
Thursday September 3, 2020 15:30 - 16:00 CEST Room 1
Hansa Biopharma
Hansa Biopharma, Sören Tulstrup (CEO)
Thursday September 3, 2020 15:30 - 16:00 CEST Room 2
Recipharm
Thomas Eldered (President and CEO)
Thursday September 3, 2020 16:00 - 16:30 CEST Room 1
Herantis Pharma
Herantis, Craig Cook (CEO)
Thursday September 3, 2020 16:00 - 16:30 CEST Room 2